TY - JOUR
T1 - Stromal changes in the aged lung induce an emergence from melanoma dormancy
AU - Fane, Mitchell E.
AU - Chhabra, Yash
AU - Alicea, Gretchen M.
AU - Maranto, Devon A.
AU - Douglass, Stephen M.
AU - Webster, Marie R.
AU - Rebecca, Vito W.
AU - Marino, Gloria E.
AU - Almeida, Filipe
AU - Ecker, Brett L.
AU - Zabransky, Daniel J.
AU - Hüser, Laura
AU - Beer, Thomas
AU - Tang, Hsin Yao
AU - Kossenkov, Andrew
AU - Herlyn, Meenhard
AU - Speicher, David W.
AU - Xu, Wei
AU - Xu, Xiaowei
AU - Jaffee, Elizabeth M.
AU - Aguirre-Ghiso, Julio A.
AU - Weeraratna, Ashani T.
N1 - Funding Information:
We thank the Core Facilities of the Wistar Institute (supported by P30CA010815) and of the Johns Hopkins Kimmel Cancer Center (P30CA00697356). A.T.W., S.M.D., M.E.F. and G.M.A. are supported by R01CA174746 and R01CA207935. M.E.F., A.T.W. and J.A.A.-G. are also supported by a Team Science Award from the Melanoma Research Alliance. G.M.A., X.X., M.H. and A.T.W. are also supported by P01 CA114046. X.X. and M.H. are also supported by P50CA174523. M.R.W. is supported by R00CA208012. H.-Y.T. is supported by R50CA221838. V.W.R. is supported by K01CA245124. This work was supported in part by the Wistar Science Discovery Fund. A.T.W. is also supported by U01CA227550, R01CA232256, a Bloomberg Distinguished Professorship and the EV McCollum Endowed Chair. For samples from patients with melanoma, we thank L. M. Schuchter, T. C. Mitchell, R. K. Amaravadi, G. C. Karakousis, R. Elenitsas, C. Miller and M. E. Ming. We thank C. McQueen for editing of the final manuscript.
Funding Information:
J.A.A.-G. is a scientific co-founder of, scientific advisory board member of, equity owner in and receives financial compensation as a consultant for HiberCell, a Mount Sinai spin-off company that is focused on therapeutics that prevent or delay the recurrence of cancer. A.T.W. is on the board of reGAIN Therapeutics. E.M.J. reports other support from Abmeta, personal fees from Genocea, personal fees from Achilles, personal fees from DragonFly, personal fees from Candel Therapeutics, other support from the Parker Institute, grants and other support from Lustgarten, personal fees from Carta, grants and other support from Genentech, grants and other support from AstroZeneca, personal fees from NextCure and grants and other support from Break Through Cancer outside of the submitted work.
Publisher Copyright:
© 2022, The Author(s), under exclusive licence to Springer Nature Limited.
PY - 2022/6/9
Y1 - 2022/6/9
N2 - Disseminated cancer cells from primary tumours can seed in distal tissues, but may take several years to form overt metastases, a phenomenon that is termed tumour dormancy. Despite its importance in metastasis and residual disease, few studies have been able to successfully characterize dormancy within melanoma. Here we show that the aged lung microenvironment facilitates a permissive niche for efficient outgrowth of dormant disseminated cancer cells—in contrast to the aged skin, in which age-related changes suppress melanoma growth but drive dissemination. These microenvironmental complexities can be explained by the phenotype switching model, which argues that melanoma cells switch between a proliferative cell state and a slower-cycling, invasive state1–3. It was previously shown that dermal fibroblasts promote phenotype switching in melanoma during ageing4–8. We now identify WNT5A as an activator of dormancy in melanoma disseminated cancer cells within the lung, which initially enables the efficient dissemination and seeding of melanoma cells in metastatic niches. Age-induced reprogramming of lung fibroblasts increases their secretion of the soluble WNT antagonist sFRP1, which inhibits WNT5A in melanoma cells and thereby enables efficient metastatic outgrowth. We also identify the tyrosine kinase receptors AXL and MER as promoting a dormancy-to-reactivation axis within melanoma cells. Overall, we find that age-induced changes in distal metastatic microenvironments promote the efficient reactivation of dormant melanoma cells in the lung.
AB - Disseminated cancer cells from primary tumours can seed in distal tissues, but may take several years to form overt metastases, a phenomenon that is termed tumour dormancy. Despite its importance in metastasis and residual disease, few studies have been able to successfully characterize dormancy within melanoma. Here we show that the aged lung microenvironment facilitates a permissive niche for efficient outgrowth of dormant disseminated cancer cells—in contrast to the aged skin, in which age-related changes suppress melanoma growth but drive dissemination. These microenvironmental complexities can be explained by the phenotype switching model, which argues that melanoma cells switch between a proliferative cell state and a slower-cycling, invasive state1–3. It was previously shown that dermal fibroblasts promote phenotype switching in melanoma during ageing4–8. We now identify WNT5A as an activator of dormancy in melanoma disseminated cancer cells within the lung, which initially enables the efficient dissemination and seeding of melanoma cells in metastatic niches. Age-induced reprogramming of lung fibroblasts increases their secretion of the soluble WNT antagonist sFRP1, which inhibits WNT5A in melanoma cells and thereby enables efficient metastatic outgrowth. We also identify the tyrosine kinase receptors AXL and MER as promoting a dormancy-to-reactivation axis within melanoma cells. Overall, we find that age-induced changes in distal metastatic microenvironments promote the efficient reactivation of dormant melanoma cells in the lung.
UR - http://www.scopus.com/inward/record.url?scp=85131315752&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131315752&partnerID=8YFLogxK
U2 - 10.1038/s41586-022-04774-2
DO - 10.1038/s41586-022-04774-2
M3 - Article
C2 - 35650435
AN - SCOPUS:85131315752
SN - 0028-0836
VL - 606
SP - 396
EP - 405
JO - Nature
JF - Nature
IS - 7913
ER -